Genfit S.A. (GNFT.PA)
EUR 3.77
(5.72%)
EUR 3.77
(5.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.89 Million EUR | -21.81% |
| 2022 | -23.72 Million EUR | -135.27% |
| 2021 | 67.25 Million EUR | 166.45% |
| 2020 | -101.22 Million EUR | -55.38% |
| 2019 | -65.14 Million EUR | 18.08% |
| 2018 | -79.52 Million EUR | -35.69% |
| 2017 | -58.6 Million EUR | -74.07% |
| 2016 | -33.66 Million EUR | -96.48% |
| 2015 | -17.13 Million EUR | -0.64% |
| 2014 | -17.02 Million EUR | -34.57% |
| 2013 | -12.65 Million EUR | -133.8% |
| 2012 | -5.41 Million EUR | 44.1% |
| 2011 | -9.68 Million EUR | -3.21% |
| 2010 | -9.38 Million EUR | -27.21% |
| 2009 | -7.37 Million EUR | -86.19% |
| 2008 | -3.96 Million EUR | -41.41% |
| 2007 | -2.8 Million EUR | -954.68% |
| 2006 | 327.7 Thousand EUR | -81.52% |
| 2005 | 1.77 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 30.31 Million EUR | 0.0% |
| 2023 Q3 | - EUR | 100.0% |
| 2023 FY | -28.89 Million EUR | -21.81% |
| 2023 Q2 | -20.85 Million EUR | 0.0% |
| 2023 Q4 | -8.03 Million EUR | 0.0% |
| 2022 Q2 | -10.39 Million EUR | 0.0% |
| 2022 Q3 | - EUR | 100.0% |
| 2022 FY | -23.72 Million EUR | -135.27% |
| 2022 Q4 | -13.32 Million EUR | 0.0% |
| 2021 Q2 | 9.05 Million EUR | 0.0% |
| 2021 Q4 | 58.2 Million EUR | 0.0% |
| 2021 FY | 67.25 Million EUR | 166.45% |
| 2020 Q4 | -48.21 Million EUR | 0.0% |
| 2020 FY | -101.22 Million EUR | -55.38% |
| 2020 Q2 | -53.01 Million EUR | 0.0% |
| 2019 Q4 | -14.01 Million EUR | 0.0% |
| 2019 FY | -65.14 Million EUR | 18.08% |
| 2019 Q2 | -51.13 Million EUR | -213.96% |
| 2019 Q1 | -16.28 Million EUR | 61.99% |
| 2018 FY | -79.52 Million EUR | -35.69% |
| 2018 Q4 | -42.84 Million EUR | 0.0% |
| 2018 Q2 | -36.67 Million EUR | -84.48% |
| 2018 Q1 | -19.88 Million EUR | 39.96% |
| 2017 Q4 | -33.11 Million EUR | 0.0% |
| 2017 FY | -58.6 Million EUR | -74.07% |
| 2017 Q1 | -14.65 Million EUR | 30.25% |
| 2017 Q2 | -22.61 Million EUR | -54.36% |
| 2016 FY | -33.66 Million EUR | -96.48% |
| 2016 Q2 | -12.66 Million EUR | -50.45% |
| 2016 Q1 | -8.41 Million EUR | -1.84% |
| 2016 Q4 | -21 Million EUR | 0.0% |
| 2015 FY | -17.13 Million EUR | -0.64% |
| 2015 Q3 | -4.28 Million EUR | 51.71% |
| 2015 Q2 | -8.87 Million EUR | -107.08% |
| 2015 Q1 | -4.28 Million EUR | 45.62% |
| 2015 Q4 | -8.26 Million EUR | -92.92% |
| 2014 FY | -17.02 Million EUR | -34.57% |
| 2014 Q1 | -4.25 Million EUR | 10.5% |
| 2014 Q3 | -4.25 Million EUR | 53.47% |
| 2014 Q2 | -9.14 Million EUR | -114.93% |
| 2014 Q4 | -7.87 Million EUR | -85.06% |
| 2013 Q3 | -3.16 Million EUR | 59.94% |
| 2013 FY | -12.65 Million EUR | -133.8% |
| 2013 Q4 | -4.75 Million EUR | -50.35% |
| 2013 Q2 | -7.89 Million EUR | -149.65% |
| 2013 Q1 | -3.16 Million EUR | 0.0% |
| 2012 Q1 | -1.35 Million EUR | 0.0% |
| 2012 Q4 | -3.16 Million EUR | -133.79% |
| 2012 FY | -5.41 Million EUR | 44.1% |
| 2012 Q2 | -1.35 Million EUR | 0.0% |
| 2012 Q3 | -1.35 Million EUR | 0.0% |
| 2011 Q3 | -2.42 Million EUR | 0.0% |
| 2011 Q1 | -2.42 Million EUR | 0.0% |
| 2011 Q2 | -2.42 Million EUR | 0.0% |
| 2011 Q4 | -1.35 Million EUR | 44.1% |
| 2011 FY | -9.68 Million EUR | -3.21% |
| 2010 Q1 | -2.34 Million EUR | 0.0% |
| 2010 Q2 | -2.34 Million EUR | 0.0% |
| 2010 Q3 | -2.34 Million EUR | 0.0% |
| 2010 Q4 | -2.42 Million EUR | -3.21% |
| 2010 FY | -9.38 Million EUR | -27.21% |
| 2009 FY | -7.37 Million EUR | -86.19% |
| 2009 Q4 | -2.34 Million EUR | -27.21% |
| 2009 Q3 | -1.84 Million EUR | 0.0% |
| 2009 Q2 | -1.84 Million EUR | 0.0% |
| 2009 Q1 | -1.84 Million EUR | 0.0% |
| 2008 Q2 | -990.12 Thousand EUR | 0.0% |
| 2008 Q4 | -1.84 Million EUR | -86.19% |
| 2008 Q3 | -990.12 Thousand EUR | 0.0% |
| 2008 Q1 | -990.12 Thousand EUR | 0.0% |
| 2008 FY | -3.96 Million EUR | -41.41% |
| 2007 Q2 | 24.45 Thousand EUR | 0.0% |
| 2007 Q3 | 24.45 Thousand EUR | 0.0% |
| 2007 Q4 | -990.12 Thousand EUR | -4149.59% |
| 2007 FY | -2.8 Million EUR | -954.68% |
| 2007 Q1 | 24.45 Thousand EUR | 0.0% |
| 2006 Q2 | 693.97 Thousand EUR | 0.0% |
| 2006 Q4 | 24.45 Thousand EUR | -96.48% |
| 2006 FY | 327.7 Thousand EUR | -81.52% |
| 2006 Q1 | 693.97 Thousand EUR | 0.0% |
| 2006 Q3 | 693.97 Thousand EUR | 0.0% |
| 2005 Q3 | 1 Million EUR | 0.0% |
| 2005 FY | 1.77 Million EUR | 0.0% |
| 2005 Q2 | 1 Million EUR | 0.0% |
| 2005 Q1 | 1 Million EUR | 0.0% |
| 2005 Q4 | 693.97 Thousand EUR | -31.06% |
| 2004 Q4 | 1 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ABIONYX Pharma SA | -3.51 Million EUR | -721.319% |
| ABIVAX Société Anonyme | -147.74 Million EUR | 80.443% |
| Adocia SA | -21.16 Million EUR | -36.537% |
| Aelis Farma SA | -5.07 Million EUR | -469.004% |
| Biophytis S.A. | -17.02 Million EUR | -69.705% |
| Advicenne S.A. | -7.03 Million EUR | -310.952% |
| genOway Société anonyme | 1.56 Million EUR | 1943.229% |
| IntegraGen SA | -171.39 Thousand EUR | -16757.741% |
| Medesis Pharma S.A. | -3.95 Million EUR | -629.74% |
| Neovacs S.A. | -8.74 Million EUR | -230.465% |
| NFL Biosciences SA | -3.74 Million EUR | -671.437% |
| Plant Advanced Technologies SA | 79.16 Thousand EUR | 36596.609% |
| Quantum Genomics Société Anonyme | -3.17 Million EUR | -811.21% |
| Sensorion SA | -22.06 Million EUR | -30.959% |
| Theranexus Société Anonyme | -6.82 Million EUR | -323.172% |
| TME Pharma N.V. | -6.73 Million EUR | -328.949% |
| Valbiotis SA | -7.36 Million EUR | -292.155% |
| TheraVet SA | -1.57 Million EUR | -1739.554% |
| Valerio Therapeutics Société anonyme | -20.34 Million EUR | -42.027% |
| DBV Technologies S.A. | -67.26 Million EUR | 57.047% |
| GeNeuro SA | -14.75 Million EUR | -95.799% |
| Innate Pharma S.A. | -7.57 Million EUR | -281.691% |
| Inventiva S.A. | -110.42 Million EUR | 73.834% |
| MaaT Pharma SA | -19.71 Million EUR | -46.544% |
| MedinCell S.A. | -25.03 Million EUR | -15.401% |
| Nanobiotix S.A. | -39.7 Million EUR | 27.219% |
| OSE Immunotherapeutics SA | -23 Million EUR | -25.61% |
| Poxel S.A. | -35.09 Million EUR | 17.657% |
| GenSight Biologics S.A. | -26.22 Million EUR | -10.198% |
| Transgene SA | -22.32 Million EUR | -29.407% |
| Valneva SE | -101.42 Million EUR | 71.513% |